| Authors: |
Groot-Kormelink PJ; Musculoskeletal Disease Area, Novartis Institutes for BioMedical Research, Basel, Switzerland., Ferrand S; Center for Proteomic Chemistry, Novartis Institutes for BioMedical Research, Basel, Switzerland., Kelley N; Analytical Sciences and Imaging, Novartis Institutes for BioMedical Research, Basel, Switzerland., Bill A; Center for Proteomic Chemistry, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America., Freuler F; Center for Proteomic Chemistry, Novartis Institutes for BioMedical Research, Basel, Switzerland., Imbert PE; Center for Proteomic Chemistry, Novartis Institutes for BioMedical Research, Basel, Switzerland., Marelli A; Genomics Institute of the Novartis Research Foundation, Novartis Institutes for BioMedical Research, San Diego, California, United States of America., Gerwin N; Musculoskeletal Disease Area, Novartis Institutes for BioMedical Research, Basel, Switzerland., Sivilotti LG; Department of Neuroscience, Physiology and Pharmacology, University College London, London, United Kingdom., Miraglia L; Genomics Institute of the Novartis Research Foundation, Novartis Institutes for BioMedical Research, San Diego, California, United States of America., Orth AP; Genomics Institute of the Novartis Research Foundation, Novartis Institutes for BioMedical Research, San Diego, California, United States of America., Oakeley EJ; Analytical Sciences and Imaging, Novartis Institutes for BioMedical Research, Basel, Switzerland., Schopfer U; Center for Proteomic Chemistry, Novartis Institutes for BioMedical Research, Basel, Switzerland., Siehler S; Center for Proteomic Chemistry, Novartis Institutes for BioMedical Research, Basel, Switzerland. |
